Public Summary Documents by Meeting
PBAC Public Summary Documents - March 2009
Public summary documents relating to the March 2009 PBAC meeting
Adalimumab, injection, 40 mg in 0.8 mL pre-filled syringe, 40 mg in 0.8 mL pre-filled pen, Humira®
Alglucosidase alfa, powder for I.V. infusion, 50 mg, Myozyme®, March 2009
Arsenic trioxide, solution for I.V. infusion, 10mg in 10mL, Phenasen®
Bimatoprost with timolol maleate, eye drops, 0.3 mg - 5 mg (base) per mL (0.03%-0.5%), 3 mL, Ganfort®
Cetuximab, solution for I.V. infusion, 100 mg in 20 mL, 100 mg in 50 mL and 500 mg in 100 mL, Erbitux®
Clindamycin phosphate with benzoyl peroxide, gel, 10 mg (base) - 50 mg per gm (1% – 5%), 25 gm, Duac® Once Daily Gel
Clopidogrel hydrogen sulfate, tablet, 75 mg (base), Iscover®, Plavix®
Dabigatran etexilate mesilate, capsules, 75 mg, 110 mg (base), Pradaxa®
Eculizumab, solution concentrate for I.V. infusion, 300 mg in 30 mL, Soliris®
Etanercept, injection set containing 4 vials powder for injection, 25 mg and 4 pre-filled syringes solvent 1 mL, injection set containing 4 vials powder for injection, 50 mg and 4 pre-filled syringes solvent 1 mL, injections, 50 mg in 1 mL single use pre-filled syringes, Enbrel®
Etravirine, tablet, 100 mg, Intelence®
Ezetimibe with simvastatin, tablets, 10 mg - 20 mg, Vytorin®
Imiquimod, cream 50 mg per g (5%), 250 mg single use sachets, 12, Aldara®
Levodopa with carbidopa monohydrate, intestinal gel, 20 mg – 5 mg (base) per mL, 100 mL, Duodopa®
Methylnaltrexone bromide, injection, 12 mg in 0.6 mL (base), Relistor®
Oxybutynin, transdermal patches, 36 mg (releasing approximately 3.9 mg per 24 hours), 8, Oxytrol®
Paricalcitol, injection, 2 micrograms in 1 mL and 5 micrograms in 1 mL; capsules, 1 microgram, 2 micrograms, Zemplar®
Pemetrexed, powder for I.V. infusion, 100 mg and 500 mg (base), Alimta®
Poly-l-lactic acid, powder for injection, 150 mg, Sculptra®
Quetiapine fumarate, tablets, 25 mg, 100 mg, 200 mg, 300 mg (base), Seroquel®
Quetiapine fumarate, tablets, 25 mg, 100 mg, 200 mg, 300 mg (base), Seroquel®
Rivaroxaban, tablet, 10 mg, Xarelto®
Thalidomide, capsule, 50 mg Thalidomide Pharmion®
Sponsor's response to the independent Review Report
Independent Review Report for Imiquimod
